Cargando…

COVID-19 et vaccins à adénovirus : expérience française de suivi renforcé de pharmacovigilance

As part of the COVID-19 vaccination campaign, the National Agency for the Safety of Medicines and Health Products and all 31 regional pharmacovigilance centers were mobilized in an exceptional reinforced vaccine pharmacovigilance surveillance system. Concerning adenovirus vaccines, Vaxzévria® and Jc...

Descripción completa

Detalles Bibliográficos
Autores principales:	Massy, Nathalie, Atzenhoffer, Marina, Boulay, Charlène, Pecquet, Pauline-Eva, Ledys, Fanny, Cracowski, Jean-Luc, Masmoudi, Kamel, Lepelley, Marion, Gras-Champel, Valérie
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Société française de pharmacologie et de thérapeutique. Published by Elsevier Masson SAS. 2023
Materias:	Pharmacovigilance
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9862661/ https://www.ncbi.nlm.nih.gov/pubmed/36759287 http://dx.doi.org/10.1016/j.therap.2023.01.005

Ejemplares similares

Pharmacovigilance des médicaments et des vaccins contre la COVID-19 durant la pandémie : comment le Réseau français des centres régionaux de pharmacovigilance a relevé le défi ?
por: Jonville-Bera, Annie Pierre, et al.
Publicado: (2023)

Monitoring the safety of drugs and COVID-19 vaccines by the French Pharmacovigilance Centers during the pandemic: A win-win bet with Health Authorities!
por: Jonville-Bera, Annie Pierre, et al.
Publicado: (2023)

Nirmatrelvir/ritonavir (Paxlovid®): French pharmacovigilance survey 2022
por: Bihan, Kevin, et al.
Publicado: (2023)

Vaccines and Bell's palsy: A narrative review
por: Bertin, Blandine, et al.
Publicado: (2023)

A day in the life of a pharmacovigilance case processor
por: Bhangale, Ritesh, et al.
Publicado: (2017)

Global research output in ‘pharmacovigilance’ during 2010–2020
por: Tyagi, Sunil
Publicado: (2022)

French organization for the pharmacovigilance of COVID-19 vaccines: A major challenge
por: Lacroix, Clémence, et al.
Publicado: (2021)

Pharmacovigilance for clinical trials in India: Current practice and areas for reform
por: Brahmachari, Ballari, et al.
Publicado: (2011)

Pharmacovigilance follow-up of patients in the context of the COVID-19 pandemic
por: Grandvuillemin, Aurélie, et al.
Publicado: (2023)

French pharmacovigilance survey of casirivimab - imdevimab monoclonal antibodies in coronavirus disease (COVID-19)
por: de Canecaude, Claire, et al.
Publicado: (2023)

Pharmacovigilance signals from active surveillance of mRNA platform vaccines (tozinameran and elasomeran)
por: Valnet-Rabier, Marie-Blanche, et al.
Publicado: (2023)

Myocarditis and pericarditis in association with COVID-19 mRNA-vaccination: cases from a regional pharmacovigilance centre
por: Istampoulouoglou, Ioanna, et al.
Publicado: (2021)

Peripheral facial palsy post SARS-CoV-2 vaccine: A regional pharmacovigilance cases series
por: Chamboux, Morgane, et al.
Publicado: (2023)

Cardiovascular adverse effects of lopinavir/ritonavir and hydroxychloroquine in COVID-19 patients: Cases from a single pharmacovigilance centre
por: Istampoulouoglou, Ioanna, et al.
Publicado: (2021)

Pharmacovigilance and assessment of drug safety reports during COVID 19
por: Desai, Mira K
Publicado: (2020)

Torsade de pointes and systemic azole antifungal agents: Analysis of global spontaneous safety reports
por: Salem, M., et al.
Publicado: (2017)

Drug safety alerts of pharmacovigilance programme of India: A scope for targeted spontaneous reporting in India
por: Thota, Prasad, et al.
Publicado: (2018)

Causality assessment: A brief insight into practices in pharmaceutical industry
por: Naidu, R. Purushotham
Publicado: (2013)

A thorough QTc study demonstrates that olmesartan medoxomil does not prolong the QTc interval
por: Mendell, Jeanne, et al.
Publicado: (2015)

Patterns of the initiation of disease-modifying antirheumatic drugs in incident rheumatoid arthritis: a German perspective based on nationwide ambulatory drug prescription data
por: Steffen, Annika, et al.
Publicado: (2018)

Understanding the molecular–pharmaceutical basis of sartan recalls focusing on valsartan
por: Ray, Avik, et al.
Publicado: (2020)

A case of intoxication with tea made from Digitalis purpurea
por: Lehmann, Anouk, et al.
Publicado: (2021)

Comparative study of the adverse event profile of hydroxychloroquine before and during the Sars-CoV2 pandemic
por: Lory, Pauline, et al.
Publicado: (2022)

Colchicine and macrolides: a cohort study of the risk of adverse outcomes associated with concomitant exposure
por: Tan, Malinda S., et al.
Publicado: (2022)

The winding 12-month journey of the AstraZeneca COVID-19 vaccine since its first administration to humans
por: Dal-Ré, Rafael
Publicado: (2023)

Safety profile of the lopinavir/ritonavir combination before and during the SARS-CoV-2 pandemic
por: Lory, Pauline, et al.
Publicado: (2022)

Role of spontaneous reporting in investigating the relationship between mRNA COVID-19 vaccines and myocarditis: The French perspective
por: Salvo, Francesco, et al.
Publicado: (2023)

Pharmacovigilance in China: Evolution and future challenges
por: Song, Haibo, et al.
Publicado: (2022)

Enhancing self-medication practices in the era of infodemic: the role of pharmacovigilance
por: Calderon-Ospina, Carlos-Alberto
Publicado: (2023)

Small intestinal injury in NSAID users suffering from rheumatoid arthritis or osteoarthritis
por: Tachecí, Ilja, et al.
Publicado: (2016)

Analysis of serious adverse event: Writing a narrative
por: Nambiar, Indu
Publicado: (2018)

Long-term use of biologic agents does not increase the risk of serious infections in elderly patients with rheumatoid arthritis
por: Kawashima, Hirotoshi, et al.
Publicado: (2016)

The response to the COVID-19 pandemic trusted in pharmacovigilance to diminish communication risk
por: Quintero, Gustavo A.
Publicado: (2022)

Global safety monitoring of COVID-19 vaccines: how pharmacovigilance rose to the challenge
por: Rudolph, Annette, et al.
Publicado: (2022)

Techniques de renforcement musculaire en réadaptation cardiaque
por: Koch, M., et al.
Publicado: (2020)

Leveraging the Variability of Pharmacovigilance Disproportionality Analyses to Improve Signal Detection Performances
por: Khouri, Charles, et al.
Publicado: (2021)

Atypical thrombosis associated with VaxZevria® (AstraZeneca) vaccine: Data from the French Network of Regional Pharmacovigilance Centres
por: Gras-Champel, Valérie, et al.
Publicado: (2021)

Le Cern renforce sa politique de transferts de technologie
Publicado: (1999)

Brookhaven : Renforcement par « booster »
Publicado: (1986)

Fetal and Neonatal Adverse Drug Reactions Associated with Biologics Taken During Pregnancy by Women with Autoimmune Diseases: Insights from an Analysis of the World Health Organization Pharmacovigilance Database (VigiBase(®))
por: Dernoncourt, Amandine, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_mds40j4rej9dar53c77nnlkcj0